Clinical Trial Update: Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low molecular weight heparin for recurrent pregnancy loss with negative antiphospholipid antibodies has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Omar Mamdouh Shaaban | Conditions: Recurrent Miscarriage | Phase 4 | Status: COMPLETED